Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. HHS Publication No PEP23-07-01-006, NSDUH Series H-58. 2023;Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report. Accessed 1 Feb 2024.

Ahmad F, Cisewski J, Rossen L, Sutton P. Products - Vital Statistics Rapid Release - Provisional Drug Overdose Data. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 30 Mar 2023.

National Institute on Drug Abuse. Addiction and Health. National Institute on Drug Abuse. Published 2020. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/addiction-health. Accessed 10 Aug 2023.

Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: a concise review. J Neurol Sci. 2020;411:116719.

Wu LT, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 2018;192:316-323.

Wu LT, Ghitza UE, Zhu H, Spratt S, Swartz M, Mannelli P. Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. Drug Alcohol Depend. 2018;186:86-93. https://doi.org/10.1016/j.drugalcdep.2018.01.008

Knickman J, Krishnan R, Pincus H. Improving access to effective care for people with mental health and substance use disorders. JAMA. 2016;316(16):1647-1648. https://doi.org/10.1001/jama.2016.13639

Winhusen T, Theobald J, Kaelber DC, Lewis D. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings. Addiction. 2019;114(8):1462-1470. https://doi.org/10.1111/add.14607.

Leung GY, Zhang J, Lin WC, Clark RE. Behavioral health disorders and adherence to measures of diabetes care quality. Am J Manag Care. 2011;17(2):144-150.

Baxter JD, Samnaliev M, Clark RE. Patterns of health care utilization for asthma treatment in adults with substance use disorders. J Addict Med. 2008;2(2):79. https://doi.org/10.1097/ADM.0b013e318160e448

Jackson CT, Covell NH, Drake RE, Essock SM. Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders. PS. 2007;58(2):270-272. https://doi.org/10.1176/ps.2007.58.2.270

Schmidt EM, Barnes J, Chen C, Trafton J, Frayne S, Harris AHS. Patient and health care factors associated with long-term diabetes complications among adults with and without mental health and substance use disorders. JAMA Network Open. 2019;2(9):e1912060. https://doi.org/10.1001/jamanetworkopen.2019.12060

Suen LW, Makam AN, Snyder HR, et al. National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014–2018. J Gen Intern Med. 2022;37(10):2420-2428. https://doi.org/10.1007/s11606-021-07069-w

Walley AY, Paasche-Orlow M, Lee EC, et al. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med. 2012;6(1):50.

Wani RJ, Wisdom JP, Wilson FA. Emergency department utilization for substance use-related disorders and assessment of treatment facilities in New York State, 2011–2013. Subst Use Misuse. 2019;54(3):482-494. https://doi.org/10.1080/10826084.2018.1517801

Motavalli D, Taylor JL, Childs E, et al. “Health is on the back burner:” multilevel barriers and facilitators to primary care among people who inject drugs. J Gen Intern Med. 2021;36(1):129-137. https://doi.org/10.1007/s11606-020-06201-6

Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depende. 2019;197:78-82.

Jones AL, Kertesz SG, Hausmann LRM, et al. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. J Subst Abuse Treat. 2020;113:107996. https://doi.org/10.1016/j.jsat.2020.02.013

Hoggatt KJ, Frayne SM, Saechao FS, Yano EM, Washington DL. Substance use disorder-related disparities in patient experiences of primary care. Health Equity. 2019;3(1):193-197. https://doi.org/10.1089/heq.2018.0069

Sharp AL, Pallegadda R, Baecker A, et al. Are Mental health and substance use disorders risk factors for missed acute myocardial infarction diagnoses among chest pain or dyspnea encounters in the emergency department? Ann Emerg Med. 2022;79(2):93-101. https://doi.org/10.1016/j.annemergmed.2021.08.016

Hirigo AT, Teshome T. The magnitude of undiagnosed diabetes and Hypertension among adult psychiatric patients receiving antipsychotic treatment. Diabetol Metab Syndr. 2020;12:1-10.

Balogh EP, Miller BT, Ball JR, The National Academies of Sciences E. Introduction. In: Improving Diagnosis in Health Care. National Academies Press (US); 2015. https://www.ncbi.nlm.nih.gov/books/NBK338600/. Accessed 8 Sept 2023.

Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153-e639.

Centers for Disease Control and Prevention. Facts About Hypertension | cdc.gov. Centers for Disease Control and Prevention. Published January 5, 2023. https://www.cdc.gov/bloodpressure/facts.htm. Accessed 30 Mar 2023.

U.S Department of Health and Human Service. High Blood Pressure in Adults: Screening - Healthy People 2030 | health.gov. Published 2021. https://health.gov/healthypeople/tools-action/browse-evidence-based-resources/high-blood-pressure-adults-screening. Accessed 10 Aug 2023.

New York City Health + Hospitals. About NYC Health + Hospitals. NYC Health + Hospitals. https://www.nychealthandhospitals.org/about-nyc-health-hospitals/. Accessed 31 Mar 2023.

Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care. Published online 2005:1130–1139.

Banerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of hypertension using electronic health records. Am J Hypertens. 2012;25(1):97-102.

CDC. All About Your A1C. Centers for Disease Control and Prevention. Published August 21, 2018. https://bit.ly/2Nc2IA0. Accessed 9 Sept 2023.

Azar KM, Shen Z, Romanelli RJ, et al. Disparities in outcomes among COVID-19 patients in a large health care system in California: Study estimates the COVID-19 infection fatality rate at the US county level. Health Affairs. 2020;39(7):1253-1262.

Pedersen AB, Mikkelsen EM, Cronin-Fenton D, et al. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157-166. https://doi.org/10.2147/CLEP.S129785

StataCorp LLC. Stata Statistical Software: Release 16 College Station, TX: StataCorp LLC, 2019; 2020.

Bielenberg J, Swisher G, Lembke A, Haug NA. A systematic review of stigma interventions for providers who treat patients with substance use disorders. J Subst Abuse Treat. 2021;131:108486. https://doi.org/10.1016/j.jsat.2021.108486

Van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Healthcare professionals’ regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend. 2014;134:92-98.

Amaral‐Sabadini MB, Saitz R, Souza‐Formigoni MLO. Do attitudes about unhealthy alcohol and other drug (AOD) use impact primary care professionals’ readiness to implement AOD‐related preventive care? Drug Alcohol Rev. 2010;29(6):655–661.

DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15(1):93-103.

Incze MA, Chen D, Galyean P, et al. Examining the primary care experience of patients with opioid use disorder: a qualitative study. J Addict Med. 2023;17(4):401. https://doi.org/10.1097/ADM.0000000000001140

Urada D, Teruya C, Gelberg L, Rawson R. Integration of substance use disorder services with primary care: health center surveys and qualitative interviews. Subst Abuse Treat Prevention Policy. 2014;9(1):1-9.

Curtis J, Harrison L. Beneath the surface: collaboration in alcohol and other drug treatment. An analysis using Foucault’s three modes of objectification. J Adv Nurs. 2001;34(6):737–744. https://doi.org/10.1046/j.1365-2648.2001.01803.x

Padwa H, Urada D, Antonini VP, Ober A, Crèvecoeur-MacPhail DA, Rawson RA. Integrating substance use disorder services with primary care: the experience in california. J Psychoact Drugs. 2012;44(4):299-306. https://doi.org/10.1080/02791072.2012.718643

Hoang T, Goetz MB, Yano EM, et al. The impact of integrated HIV care on patient health outcomes. Med Care. 2009;47(5):560-567. https://doi.org/10.1097/MLR.0b013e31819432a0

Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666-668.

Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63. https://doi.org/10.1161/CIR.0000000000000803

Franklin SS, Thijs L, Hansen TW, O’brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–987.

Hsu C, Hansell L, Ehrlich K, et al. Primary care physician beliefs and practices regarding blood pressure measurement: results from BP-CHECK qualitative interviews. BMC Primary Care. 2023;24(1):30. https://doi.org/10.1186/s12875-022-01950-1

Vischer AS, Burkard T. Principles of Blood Pressure Measurement – Current Techniques, Office vs Ambulatory Blood Pressure Measurement. In: Islam MdS, ed. Hypertension: From Basic Research to Clinical Practice. Advances in Experimental Medicine and Biology. Springer International Publishing; 2017:85–96. https://doi.org/10.1007/5584_2016_49

McVicker JT. Blood pressure measurement - Does anyone do it right?: An assessment of the reliability of equipment in use and the measurement techniques of clinicians. J Fam Plan Reprod Health Care. 2001;27(3):163. https://doi.org/10.1783/147118901101195407

Wall HK, Hannan JA, Wright JS. Patients With undiagnosed hypertension: hiding in plain sight. JAMA. 2014;312(19):1973-1974. https://doi.org/10.1001/jama.2014.15388

Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245-1254.

Christian NJ, Zhou X, Radhakrishnan R. Substance use disorder and health outcomes in COVID-19—the need for a better research method to determine substance use exposure. JAMA Psychiatry. 2023;1;80(9):968.

Guo W, Zhou Q, Jia Y, Xu J. Increased levels of glycated hemoglobin A1c and iron deficiency anemia: a review. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2019;25:8371.

Eckhardt BJ, Holzman RS, Kwan CK, Baghdadi J, Aberg JA. Glycated Hemoglobin A1c as screening for diabetes mellitus in HIV-infected individuals. AIDS Patient Care STDs. 2012;26(4):197-201. https://doi.org/10.1089/apc.2011.0379

Committee on the Science of Changing Behavioral Health Social Norms, Board on Behavioral, Cognitive, and Sensory Sciences, Division of Behavioral and Social Sciences and Education, National Academies of Sciences, Engineering, and Medicine. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change. National Academies Press (US); 2016. http://www.ncbi.nlm.nih.gov/books/NBK384915/. Accessed 10 Aug 2023.

Executive Office of The President Office of National Drug Control Policy. The Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One. Published online 2021. https://www.whitehouse.gov/wp-content/uploads/2021/03/BidenHarris-Statement-of-Drug-Policy-Priorities-April-1.pdf?fbclid=IwAR2TBk34U_XRqlqK_pAYnUd_9f7zY3IbCQI9KxI6S5eYeRJdFzl9B09hZ84. Accessed 1 Feb 2024.